Cas:637027-41-9 methyl 5-chloro-4-hydroxy-1-methyl-2-oxo-quinoline-3-carboxylate manufacturer & supplier

Chemical Name:methyl 5-chloro-4-hydroxy-1-methyl-2-oxo-quinoline-3-carboxylate

CAS.NO:637027-41-9

Synonyms:3-Quinolinecarboxylic acid,5-chloro-1,2-dihydro-4-hydroxy-1-Methyl-2-oxo-,Methyl ester

Molecular Formula:C₁₂H₁₀ClNO₄

Molecular Weight:267.66500

HS Code:2933790090

Physical and Chemical Properties:

Melting point:N/A

Boiling point:N/A

Density:N/A

Index of Refraction:

PSA:68.53000

Exact Mass:267.03000

LogP:1.68410

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 3-Quinolinecarboxylic acid,5-chloro-1,2-dihydro-4-hydroxy-1-Methyl-2-oxo-,Methyl ester chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,3-Quinolinecarboxylic acid,5-chloro-1,2-dihydro-4-hydroxy-1-Methyl-2-oxo-,Methyl ester physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,3-Quinolinecarboxylic acid,5-chloro-1,2-dihydro-4-hydroxy-1-Methyl-2-oxo-,Methyl ester Use and application,3-Quinolinecarboxylic acid,5-chloro-1,2-dihydro-4-hydroxy-1-Methyl-2-oxo-,Methyl ester technical grade,usp/ep/jp grade.

Related News: Schimpke, an assistant professor in the Division of Minimally Invasive and Bariatric Surgery at Rush Medical College in Chicago, and his colleagues point out that obesity is linked to a considerably higher risk for developing upwards of 40 different serious illnesses, including heart disease and diabetes. methyl 5-chloro-4-hydroxy-1-methyl-2-oxo-quinoline-3-carboxylate manufacturer He said the FDA made its decision by fiat, and had not asked its advisors to consider whether the drug’s ability to remove a type of brain plaques known as beta amyloid would improve outcomes for patients. methyl 5-chloro-4-hydroxy-1-methyl-2-oxo-quinoline-3-carboxylate supplier He said the FDA made its decision by fiat, and had not asked its advisors to consider whether the drug’s ability to remove a type of brain plaques known as beta amyloid would improve outcomes for patients. methyl 5-chloro-4-hydroxy-1-methyl-2-oxo-quinoline-3-carboxylate vendor The entire set of results “strongly support” the Darzalex-Rd combo as a new standard of care for newly diagnosed, transplant-ineligible multiple myeloma patients, Thierry Facon, M.D., an investigator of the MAIA trial, said in a statement. methyl 5-chloro-4-hydroxy-1-methyl-2-oxo-quinoline-3-carboxylate factory Schimpke, an assistant professor in the Division of Minimally Invasive and Bariatric Surgery at Rush Medical College in Chicago, and his colleagues point out that obesity is linked to a considerably higher risk for developing upwards of 40 different serious illnesses, including heart disease and diabetes.